Navigation Links
Arzerra(TM) (ofatumumab) Demonstrates High Response Rates in Patients With Fludarabine Refractory Chronic Lymphocytic Leukemia (CLL)
Date:12/8/2008

te, and other factors. For a further discussion of these risks, please refer to the section "Risk Management" in Genmab's Annual Report, which is available on www.genmab.com. Genmab does not undertake any obligation to update or revise forward looking statements in this press release nor to confirm such statements in relation to actual results, unless required by law.

NOTES:

(*) The percentage of patients whose tumor shrinks or disappears after treatment

(**) A decrease in the extent of cancer in the body, in response to treatment

(***) The disappearance of all signs of cancer in response to treatment.

References

(1) Osterborg A, Kipps et al. Ofatumumab (HuMax-CD20), a Novel CD20 Monoclonal Antibody, Is An Active Treatment for Patients with CLL Refractory to Both Fludarabine and Alemtuzumab or Bulky Fludarabine-Refractory Disease: Results from the Planned Interim Analysis of An International Pivotal Trial. Abstract #328. Presented at the American Society of Hematology Annual Meeting 2008

(2) Shanafelt TD, Byrd JC, et al. Narrative review: initial management of newly diagnosed, early-stage chronic lymphocytic leukemia. Ann Intern Med. 2006 Sep 19;145(6):435-47.

(3) Tam CS, O'Brien S, et al. The natural history of fludarabine-refractory chronic lymphocytic leukemia patients who fail alemtuzumab or have bulky lymphadenopathy. Leukemia and Lymphoma 2007;48(10):1931-1939

(4) Hagenbeek A, Gadeberg O, et al. First clinical use of ofatumumab, a novel fully human anti-CD20 monoclonal antibody in relapsed or refractory follicular lymphoma: results of a phase 1/2 trial. Blood, 2008; 111: 5486-5495

(5) Teeling JL, Mackus, W,J., et al. The Biological Activity of Human CD20 Monoclonal Antibodies Is Linked to Unique Epitopes on CD20. J Immunol 2006; 177: 362-371

(6) Glennie MJ, Frenc
'/>"/>

SOURCE GlaxoSmithKline
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Cytokine Demonstrates Oral Efficacy of Small-Molecule MIF Inhibitors
2. Lpath Demonstrates Strong Safety Profile of Lead Drug Candidate, Sphingomab(TM), in Non-Human Primates
3. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
4. New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia
5. Cypher(R) Sirolimus-Eluting Coronary Stent Demonstrates Sustained Clinical Benefits Compared to Bare Metal Stents in Five-Year Randomized Clinical Trial With No Differences in Long-Term Safety
6. Lpath Demonstrates Preclinical Efficacy of Lpathomab(TM) and Initiates Humanization Process
7. R7128 Demonstrates Safety and Potent Antiviral Activity in HCV-Infected Patients
8. Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial
9. New Study Demonstrates 4 Year Olds Fed Enfamil LIPIL(R) as Infants Have Brain and Eye Outcomes Similar to Breastfed Babies
10. ACTOS(R) (pioglitazone HCl) Demonstrates Reduced Risk of Ischemic Cardiovascular Disease in Patients with Type 2 Diabetes
11. Oritavancin Demonstrates Superior In Vitro Activity to Vancomycin and Metronidazole Against C. Difficile Bacteria
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... , Aug. 29, 2014 Research and ... "Research and Development Trend Forecast of Pharmaceutical Equipment Market ... Research and Development Trend Forecast of Pharmaceutical ... mainly analyzes China,s pharmaceutical equipment ... & demand, competition landscape, and business performance of domestic ...
(Date:8/29/2014)... , Aug. 29, 2014 Diseases largely ... a generation ago are returning. Measles was declared eliminated ... in 2014 as of August 15—the highest incidence in ... public health department declared whooping cough a problem of ... are getting sick and dying from these preventable diseases—in ...
(Date:8/29/2014)... 29, 2014  In part four of ... hospital pharmacy as a strategic asset, Mary Baxter, ... for Cardinal Health,s Innovation Delivery Solutions business, discusses how ... both hospitals and patients. "Every hospital pharmacist ... of their job in a value-based healthcare world," Baxter ...
Breaking Medicine Technology:Research and Development Trend Forecast of Pharmaceutical Equipment Market in China, 2014-2018 2Vaccines at the Crossroads: Outbreaks On the Rise Across America 2Vaccines at the Crossroads: Outbreaks On the Rise Across America 3Five Ways Hospital Pharmacies Can Fulfill Their Quality Care Mission 2Five Ways Hospital Pharmacies Can Fulfill Their Quality Care Mission 3Five Ways Hospital Pharmacies Can Fulfill Their Quality Care Mission 4
... Diamyd Medical AB ( http://www.omxgroup.com, OMX: DIAM B; ... http://www.otcqx.com, ... DIAM B)(OTC: DMYDY)announced today that the Swedish Medical Products,Agency (MPA) ... the therapeutic diabetes vaccine Diamyd(R)., (Logo: http://www.newscom.com/cgi-bin/prnh/20080314/297194 ...
... Company Initiates Phase 2a Trial in Patients with Stable Asthma ... Exercise-Induced Bronchoconstriction -, ... clinical program studying an investigational treatment targeting,interleukin-9 (IL-9) has advanced ... The company initiated a Phase 2a clinical trial designed to,assess ...
Cached Medicine Technology:Diamyd(R) Diabetes Vaccine Receives Approval to Start Phase III Trials in Europe 2MedImmune Advances Clinical Development of Antibody Targeting Interleukin-9 in Patients with Asthma 2
(Date:8/31/2014)... 2014 Brook Forest Voices , ... “Simplicity & Sophistication: Short Stories of Wisdom and Kindness ... Dr. James W. Jackson author, speaker, humanitarian and cultural ... compresses his vast volume of meticulously handwritten notes ... 150 countries on behalf of Project C.U.R.E . ...
(Date:8/31/2014)... With the NCAA set to undergo ... an interview with Yale University Associate Athletic Director Steve ... approach to ensuring student-athlete experience that is consistent with ... a number of key factors that contribute to a ... factor in creating this culture seems simple at first. ...
(Date:8/31/2014)... 31 August 2014: Wine only protects against cardiovascular disease ... the In Vino Veritas (IVV) study presented at ESC ... Republic. , Professor Taborsky said: "This is the first ... wine on markers of atherosclerosis (1) in people at ... moderate wine drinking was only protective in people who ...
(Date:8/30/2014)... 2014: A new method to predict the optimal ... presented at ESC Congress today by Dr Benjamin Dahan ... 350 AEDs located in public places for optimal prevention ... Dahan said: "Out of hospital cardiac arrest is a ... between 50 and 100 per 100 000 in the ...
(Date:8/30/2014)... Barcelona, Spain Sunday 31 August 2014: A ... wristwatch and powered by heart motion was presented ... from Switzerland. The prototype device does not require ... in the Cardiovascular Engineering Group at ARTORG, University ... factor in today,s medical implants. Once they reach ...
Breaking Medicine News(10 mins):Health News:Brook Forest Voices Announces End of Summer Release! Dr. James Jackson’s, “Simplicity & Sophistication” Audiobook 2Health News:Yale University’s Steve Conn Discusses NCAA Football, Student-Athlete Experience, & Social Media SCI Talk Interview 2Health News:Yale University’s Steve Conn Discusses NCAA Football, Student-Athlete Experience, & Social Media SCI Talk Interview 3Health News:Wine only protects against CVD in people who exercise 2Health News:New method predicts optimal number and location of AEDs 2Health News:Batteryless cardiac pacemaker is based on automatic wristwatch 2
... HILLS, Calif., June 11 The Jonsson Cancer,Center ... raising,private funds for highest priority cancer research, hosts ... 21, at the Beverly Wilshire Hotel. FOX,Broadcasting Company ... Humanitarian Award. Jimmy Kimmel hosts the event and ...
... LAUREL, N.J., June 11 MedQuist Inc.,(Pink Sheets: MEDQ.PK). ... the District of New Jersey dismissed the South Broward ... and good cause shown,within 60 days, to reopen the ... in the process of informing the court that the ...
... Institute of Allergy and Infectious Diseases (NIAID), part of the ... George W. Bush with the Presidential Medal of Freedom at ... , The White House noted today that Dr. Fauci ... knowledge. His efforts to advance our understanding and treatment of ...
... PLAINS, NY Experts from throughout the United States will ... the growing crisis of preterm birth. , The conference, ... RADM, USPHS and the Eunice Kennedy Shriver National Institute of ... 16 and 17 in Rockville, MD. It is a ...
... While consumers are increasing demand for pork produced ... such conditions carry bacteria and parasites associated with ... A comparison of swine raised in antibiotic-free and ... outdoors without antibiotics had higher rates of three ...
... some into remission, study says , , WEDNESDAY, June ... golimumab to weekly doses of methotrexate helped most ... into remission, two new studies show. , The ... biologic therapy drug, were scheduled to be presented ...
Cached Medicine News:Health News:American Idol Winner David Cook to Perform at and Jimmy Kimmel to Host Jonsson Cancer Center Foundation's 'Taste for a Cure' on June 21 2Health News:MedQuist Announces Dismissal of South Broward Litigation and Appointment of New Interim President & CEO 2Health News:MedQuist Announces Dismissal of South Broward Litigation and Appointment of New Interim President & CEO 3Health News:MedQuist Announces Dismissal of South Broward Litigation and Appointment of New Interim President & CEO 4Health News:Experts to develop national response to growing crisis of premature birth 2Health News:Pigs raised without antibiotics more likely to carry bacteria, parasites 2Health News:Pigs raised without antibiotics more likely to carry bacteria, parasites 3Health News:Pigs raised without antibiotics more likely to carry bacteria, parasites 4Health News:Golimumab Eases Rheumatoid Arthritis Symptoms 2
... (IFA) test for the detection and semi-quantitation ... Louis Encephalitis virus (SLE), Western Equine Encephalitis ... and California Encephalitis/La Crosse virus (CE). Each ... individual spots of SLE, WEE, EEE, and ...
... Indirect immunofluorescent antibody (IFA) ... and semi-quantitation of human ... Epstein-Barr viral capsid antigen ... ten 12-well slides, FITC ...
... immunofluorescent (ACIF) antibody test ... semi-quantitation of human serum ... antigens of Epstein-Barr virus ... ten 12-well slides, EBNA ...
... DonJoy SpinaLogic is a portable, battery-powered, micro-controlled, ... adjunct electromagnetic treatment to primary lumbar spinal ... This treatment has been shown in ... healing process begin working. Clinical studies have ...
Medicine Products: